S2Medical AB (S2M) — Cash Flow-to-Debt Ratio
S2Medical AB (S2M) has a Cash Flow-to-Debt Ratio of 0.10x as of December 2025, meaning its operating cash flow of Skr676.00K could theoretically repay 0% of its total liabilities (Skr6.90 Million) in one year. See S2Medical AB (S2M) FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
S2Medical AB Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for S2Medical AB across 10 annual periods. Also explore S2M shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for S2Medical AB (2016–2025)
Year-by-year debt coverage analysis for S2Medical AB. For market capitalisation and broader financial context, see how much is S2Medical AB worth.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.10x | Skr675.00K | Skr6.90 Million | ▼ -87.8% |
| 2024 | 0.80x | Skr5.03 Million | Skr6.29 Million | ▲ +195.7% |
| 2023 | -0.84x | Skr-16.52 Million | Skr19.75 Million | ▲ +45.8% |
| 2022 | -1.54x | Skr-28.13 Million | Skr18.22 Million | ▼ -17.7% |
| 2021 | -1.31x | Skr-19.67 Million | Skr15.00 Million | ▲ +12.8% |
| 2020 | -1.50x | Skr-12.75 Million | Skr8.48 Million | ▲ +50.8% |
| 2019 | -3.05x | Skr-17.10 Million | Skr5.60 Million | ▼ -32.5% |
| 2018 | -2.31x | Skr-12.75 Million | Skr5.53 Million | ▼ -49.8% |
| 2017 | -1.54x | Skr-5.85 Million | Skr3.80 Million | ▼ -86.6% |
| 2016 | -0.82x | Skr-3.03 Million | Skr3.67 Million | — |